Bio-Rad Laboratories, Inc. BIO.B

365.08 0.00 0.00% as of 24 Sep
Market cap
$10.3B
P/E
43.8×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
11.12 0.00 0.00 0.00 5.07 4.49 6.27 18.88 61.72 190.78
P/S ratio
3.28 3.58 3.51 4.30 7.38 6.71 4.77 3.00 3.27 2.61
P/FCF ratio
22.49 31.49 42.49 143.80 40.00 35.61 29.95 42.89 0.00 72.05
P/Operating CF
51.37 73.97 115.62 151.40 126.21 58.06 69.02 65.35 101.90 56.91
P/B ratio
1.14 1.40 1.07 1.25 1.58 1.73 1.92 1.71 2.41 2.09
Price to Tangible BV
1.26 1.57 1.17 1.36 1.65 1.82 2.06 1.87 3.14 2.78
EV/Sales
3.15 3.40 3.35 4.09 7.08 6.33 4.48 2.82 3.12 2.41
EV/EBITDA
172.31 32.43 26.50 23.74 41.37 38.23 45.06 0.00 29.92 30.04
EV/Operating CF
15.28 19.16 23.88 58.92 30.92 27.54 22.60 22.60 64.72 23.06
EV/FCF
21.59 29.90 40.62 136.67 38.39 33.57 28.10 40.33 (610.54) 66.58
Quick Ratio
3.87 4.53 4.02 4.03 1.91 2.24 1.67 2.76 2.44 2.58
Current Ratio
5.62 6.48 5.83 5.55 2.92 3.39 2.41 4.49 3.93 3.91
Net Debt/EBITDA
(7.15) (1.72) (1.22) (1.24) (1.73) (2.33) (2.96) 3.98 (2.73) (7.36)
Debt/Assets
11.37% 12.83% 9.75% 8.87% 0.06% 0.11% 5.49% 7.83% 10.18% 11.28%
Debt/Equity
0.16 0.18 0.14 0.12 0.00 0.00 0.08 0.11 0.15 0.17
Asset Turnover
0.26 0.24 0.21 0.18 0.19 0.24 0.34 0.46 0.53 0.55
Operating CF/Net income
0.70 (0.25) (0.59) (0.05) 0.16 0.15 0.26 0.78 0.85 8.31
Capex/Depreciation
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
10.84% (24.09%) (6.94%) (31.14%) 36.11% 48.79% 35.98% 10.52% 4.44% 1.03%
ROA
7.62% (17.03%) (4.94%) (23.18%) 27.65% 36.36% 25.83% 7.40% 3.01% 0.69%
ROIC
0.41% 2.75% 2.54% 3.34% 2.44% 2.96% 2.83% (1.79%) 2.86% 1.61%
Return on Tangible Assets
25.94% (59.67%) (20.86%) (117.48%) 233.60% 190.74% 99.14% 17.57% 6.21% 1.40%
Average Days of Receivables
65.08 64.35 66.82 64.43 52.90 60.14 62.00 62.57 78.55 65.71
Research and Development Expense of Revenue
0.00% 0.00% 9.26% 9.17% 8.92% 8.55% 8.77% 8.70% 11.58% 9.95%
Selling, General and Administrative Expense of Revenue
32.68% 31.72% 31.51% 29.54% 30.01% 31.38% 35.67% 36.46% 37.35% 39.39%
Intangible Assets out of Total Assets
0.07 0.08 0.06 0.05 0.03 0.04 0.05 0.06 0.16 0.17
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(0.03) 0.03 (0.05) (0.06) (0.10) (0.06) (0.01) 0.06 0.09 0.11
Graham Number
414.65 0.00 0.00 0.00 1,213.40 977.42 505.67 192.17 92.64 43.50
Earnings Yield
9.00% (19.96%) (6.69%) (29.98%) 19.73% 22.28% 15.94% 5.30% 1.62% 0.52%
Free Cash Flow Yield
4.45% 3.18% 2.35% 0.70% 2.50% 2.81% 3.34% 2.33% (0.16%) 1.39%
Revenue per Share
94.75 90.97 91.45 94.08 97.97 85.52 77.46 76.73 72.84 70.25
Operating CF per Share
19.52 16.13 12.84 6.53 22.44 19.65 15.34 9.57 3.51 7.34
Capex per Share
(5.78) (5.87) (5.36) (3.83) (4.48) (3.53) (3.00) (4.21) (3.88) (4.80)
Free Cash Flow per Share
13.74 10.27 7.48 2.70 17.96 16.12 12.34 5.36 (0.37) 2.54
Cash per Share
56.51 59.00 55.21 60.31 29.35 33.48 37.54 28.50 25.65 28.67
Shareholders Equity per Share
273.40 232.84 299.26 322.82 458.76 331.90 192.84 134.75 98.81 87.61
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
273.40 232.84 299.26 322.82 458.76 331.90 192.84 134.75 98.81 87.61
Free Cash Flow
374.70 289.70 218.40 80.30 535.77 479.89 368.31 159.98 (10.90) 74.89
Working Capital
2,389.20 2,562.50 2,525.50 2,589.27 1,309.54 1,508.30 1,274.66 1,572.68 1,473.95 1,373.20
Capital Expenditures
(157.50) (165.50) (156.50) (114.10) (133.69) (105.08) (89.58) (125.51) (115.04) (141.17)
Net Current Asset Value
(216.70) 235.50 (509.60) (728.44) (2,123.68) (952.84) (73.65) 432.74 633.89 573.18
EV/EBIT
172.31 32.43 26.50 23.74 41.37 38.23 45.06 0.00 56.52 89.42
Capex to Sales
0.06 0.06 0.06 0.04 0.05 0.04 0.04 0.05 0.05 0.07
Net Profit Margin
29.42% (71.86%) (23.86%) (129.45%) 145.57% 149.83% 76.08% 15.97% 5.66% 1.26%
Price to Operating Income
179.46 34.15 27.73 24.97 43.10 40.57 48.03 0.00 59.25 96.77
Other line items
Depreciation/Fixed assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash ROIC
(0.08%) (0.77%) (1.33%) (2.41%) 1.08% 0.86% (0.57%) (4.20%) (9.44%) (7.07%)
Accounts Receivable Turnover
5.66 5.45 5.43 6.10 6.93 6.27 5.89 5.34 5.16 5.42
Accounts Payable Turnover
9.89 8.90 8.90 8.92 9.13 8.99 9.19 8.28 7.25 7.28
Inventory Turnover
1.66 1.54 1.66 1.91 2.15 1.88 1.85 1.81 1.74 1.83
Average Days of Payables
37.87 37.59 42.42 39.91 40.34 45.95 37.04 41.92 50.74 52.26
Days of Inventory on Hand
217.45 233.58 228.95 212.61 162.61 205.03 191.73 199.85 223.25 206.09
Average Receivables
456.55 470.75 491.82 459.09 421.48 406.05 392.56 428.65 418.60 381.92
Average Payables
125.65 133.45 139.82 138.49 140.70 123.23 114.73 128.82 134.15 127.75
Average Inventory
750.35 770.25 749.91 645.78 597.25 588.13 568.91 589.31 559.88 507.59
Average Assets
9,970.30 10,831.60 12,900.39 15,650.53 15,386.01 10,490.74 6,809.96 4,942.04 4,061.76 3,780.11
Average Common Equity
7,011.45 7,655.25 9,178.23 11,650.25 11,782.59 7,817.50 4,887.69 3,475.29 2,754.71 2,534.83

Fold the line items

Columns are period end dates